In a detailed analysis by the Tampa Bay Times, experts have outlined five crucial measures to enhance safety in the kratom marketplace. This comes in the wake of numerous deaths in Florida linked to kratom use, often involving other substances. The article highlights the lack of regulation and information on kratom products, which can produce opioid-like effects.
Key recommendations include limiting the potency of kratom products, especially concentrated extracts that are far stronger than traditional powders. Researchers suggest capping the levels of mitragynine, kratom’s main active compound, in these products.
Another significant proposal is to warn consumers about the dangers of mixing kratom with other substances. Kratom can interact with various medications, potentially leading to toxic levels in the bloodstream.
The article also emphasizes the need for robust enforcement mechanisms for kratom regulations, including product registration and inspections. Additionally, it calls for kratom manufacturers to adhere to good manufacturing practices, ensuring product safety and consistency.
Finally, there’s a push to crack down on kratom being marketed as a drug, which is currently not allowed due to the lack of FDA approval. The article underscores the importance of these steps in making the kratom marketplace safer for consumers.
